Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LDN Immune Monitoring in Fibromyalgia
NCT02107014Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Mar 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-blind, single-arm trial of naltrexone in fibromyalgia (FM), sponsored by University of Alabama at Birmingham. Primary endpoints: Change in Plasma Inflammatory Markers (63-plex assay) at 10 weeks, Change in Pain From Baseline at 10 weeks and 1 more. Started Mar 2014; status: completed.
02
Drugs
naltrexone
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT02107014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02107014.